Table 2. Induction of apoptosis by OHP, TFT or both drugs in WiDr, H630 and SW1116 cells.
Cell line
|
|||
---|---|---|---|
Drug Treatment | WiDr | H630 | SW1116 |
Control | 2.3±0.6** | 1.6±0.3** | 2.9±0.2** |
TFT IC75 72 h | 16.2±2.5 | 6.7±0.5** | 10.6±1.7 |
OHP IC75 72 h | 13.2±1.7 | 8.2±3.0 | 13.7±2.2 |
OHP IC75+TFT IC75 72 h | 18.8±3.1* | 13.1±1.0* | 20.6±1.5** |
OHP IC75 48 h alone | 8.9±1.2* | 3.5±0.3** | 7.0±0.7** |
TFT IC75 24 h>OHP IC75 48 h | 9.3±1.1* | 7.0±0.7* | 9.0±0.9* |
The cells were exposed 72 h to [IC75] of the drugs, either alone or in combination. These concentrations were: WiDr: 25 μM TFT, 10 μM OHP; H630: 10 μM TFT, 3.5 μM OHP and SW1116: 100 μM TFT, 10 μM OHP. Values (%) represent [apoptosis population]/[total cell population] and are expressed as means±s.e.m. (n=3). Compared to OHP alone: *P<0.05; **P<0.01 ((un)paired t-test).